Fifth disease - Mate Tuarima
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
16-marama te pakeke me te Mate Tuarima (Fifth disease) ― Ka whero nga paparinga e rua, me te mea e pakipakihia ana, ka puta mai nga maculopapular rashes ki runga i te tinana.
Erythema ki nga paparinga e rua.
relevance score : -100.0%
ReferencesKo te Fifth disease (fifth disease), e mohiotia ana ko te erythema infectiosum (erythema infectiosum), he mate huaketo na te parvovirus B19 (parvovirus B19) tangata. Ka kaha ake i roto i ngā tamariki, ka pā ki te hunga kei waenga i te 4 ki te 14 tau. I te nuinga o te wā ka timata ngā tohu ki te kirikiri (fever) ngawari, ki te māhunga (headache), ki te korokoro (rash), me te āhua o te rewharewha (cold‑like symptoms) pērā i te huka me te pupuri ihu. Ka taea e ngā tamariki te āhua o te kiri whero i runga i te mata, he rite ki te “slapped‑cheek disease” (slapped‑cheek disease), me te āhua o te ponana (lacy rash) ki te tinana, ringa, me ngā waewae. Inā roto i ngā pakeke, ko te māmae (joint aches) he amuamu noa, tērā pea ka puta i ngā wiki i muri i te mate tuatahi. Ko te mea nui, tata ki te 20 ki te 30 % o ngā pakeke kua pangia e te parvovirus B19 kāore pea he tohu‑tohu (asymptomatic).
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Kei te 33 % te morearea o te tuku parvovirus B19 mai i te whaea ki te peipi, me te 3 % o ngā wahine kua pangia e pā ana ki ngā raruraru i roto i a rātou kohungahunga. Ka pangia te whaea i mua i te 20 wiki o te haputanga, ka piki ake te tūpono o ngā raruraru pērā i te raruraru toto (hemolysis), te hanga wai (hydrops fetalis), me te ngaro o te peipi. Hei timata ki te whakahaere i tēnei mate, me tirotiro mēnā kua pā te mate ki te parvovirus mā te whakamātautau mō ētahi antibodies (IgM). Mēnā kāore he rongo o mua i te whakamātautau engari ka tohu he mate nō tata nei, me aro turuki te mātāmua i te wā e hāpu ana, tae atu ki te tirotiro i te ultrasound (ultrasound) ki te tirotiro mō ētahi take hauora o te peipi.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
mate tuarima (fifth disease) ka timata ki te huka iti (low‑grade fever), pēke (headache), pupuri (rash), me nga tohu āhua makariri (cold‑like symptoms), penei i te ihu pupuhi, te ihu pupuhi ranei. Ka pahemo enei tohu, katahi i etahi ra i muri mai, ka puta te pupuhi. Ka kitea te kiri whero kanapa ki te mata, ina koa nga paparinga (no reira te ingoa “mate paparinga paparinga (slapped‑cheek disease)”). I tua atu i nga paparinga whero, he maha nga wa ka puta nga tamariki i te whero, i te rekereke (lacy rash) i runga i te toenga o te tinana, ko nga ringaringa o runga, te rama, me nga waewae te waahi nui.
He ngawari te mate, engari ki nga wahine hapu, ko te mate i te marama tuatahi kua honoa ki te hydrops fetalis, ka mate ohorere.
○ Maimoatanga
Kaore e hiahiatia he maimoatanga motuhake na te mea ka pai ake te waa.